Ryman Healthcare Limited (RYHTY)

PNK: RYHTY · Real-Time Price · USD

7.55

0.25 (3.42%)

At close: Apr 22, 2025, 11:12 AM

Ryman Healthcare Income Statement

Financials in NZD. Fiscal year is April - March.

Fiscal Year	Q4 2024	Q2 2024	Q4 2023	Q2 2023	Q4 2022	Q2 2022	Q4 2021	Q2 2021	Q4 2020	Q2 2020	Q4 2019	Q2 2019	Q4 2018	Q2 2018	Q4 2017	Q2 2017	Q4 2016	Q2 2016
Period Ending	Mar 31, 2024	Sep 30, 2023	Mar 31, 2023	Sep 30, 2022	Mar 31, 2022	Sep 30, 2021	Mar 31, 2021	Sep 30, 2020	Mar 31, 2020	Sep 30, 2019	Mar 31, 2019	Sep 30, 2018	Mar 31, 2018	Sep 30, 2017	Mar 31, 2017	Sep 30, 2016	Mar 31, 2016	Sep 30, 2015
Revenue	682.54M	606.85M	560.11M	528.13M	503.76M	477.44M	452.41M	435.64M	422.11M	401.83M	381.8M	364.1M	342.1M	315.17M	288.73M	272.53M	260.36M	243.99M
Cost of Revenue	678.07M	610.77M	579.88M	546.85M	501.94M	469.81M	441.87M	410.69M	377.87M	331.5M	301.55M	288.49M	266.46M	248.6M	225.57M	211.12M	203.07M	193.59M
Gross Profit	4.47M	-3.93M	-19.77M	-18.72M	1.82M	7.63M	10.54M	24.95M	44.25M	70.33M	80.26M	75.62M	75.64M	66.57M	63.16M	61.41M	57.29M	50.4M
Operating Income	-13.14M	-3.93M	-19.77M	-18.72M	1.82M	7.63M	10.54M	24.95M	44.25M	56.26M	54.93M	52.04M	53.48M	48.94M	48.23M	46.91M	43.53M	37.35M
Interest Income	2.33M	3.05M	2.14M	15.78M	15.46M	53K	103K	409K	547K	9.91M	18.43M	17.04M	16.14M	12.99M	10.2M	9.42M	8.82M	9.4M
Pretax Income	-144.93M	132.33M	206.2M	664.86M	722.08M	472.52M	410.5M	187.93M	171.15M	355.25M	329.42M	355.18M	388.86M	371.87M	362.99M	368.6M	309.33M	271.35M
Net Income	4.78M	250.53M	257.84M	605.39M	692.87M	492.13M	423.06M	288.83M	264.71M	344.73M	325.99M	355.12M	388.22M	372.32M	356.69M	359.85M	305.42M	266.59M
Selling & General & Admin	231.56M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	2.2M	2.2M	1.58M	1.58M	n/a	n/a	1.1M	1.1M	822K
Research & Development	16.07M	11.74M	11.74M	5.11M	5.11M	5.14M	5.14M	3.61M	3.61M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Expenses	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Operating Expenses	382.66M	201.9M	294.44M	670.46M	710.19M	451.25M	369.38M	235.85M	216.69M	289.65M	267.58M	296.6M	329.36M	318.29M	310.03M	316.6M	260.87M	230.35M
Interest Expense	50.64M	207.72M	205.37M	34.77M	30.66M	25.02M	19.36M	19.34M	19.31M	9.56M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	925.7M	610.77M	579.88M	546.85M	501.94M	469.81M	441.87M	410.69M	377.87M	454.89M	569.13M	585.09M	595.82M	566.9M	535.61M	527.72M	463.94M	423.94M
Income Tax Expense	63.2M	-118.21M	-51.64M	59.47M	29.21M	-19.61M	-12.56M	-100.9M	-93.56M	10.51M	3.43M	657K	1.24M	2.32M	9.06M	8.75M	3.91M	4.76M
Shares Outstanding (Basic)	137.53M	137.53M	114.63M	106.09M	106.09M	106.09M	106.09M	106.09M	106.09M	106.09M	100M	100M	100M	100M	100M	100M	100M	100M
Shares Outstanding (Diluted)	137.53M	137.53M	114.63M	106.09M	106.09M	106.09M	106.09M	106.09M	106.09M	106.09M	100M	100M	100M	100M	100M	100M	100M	100M
EPS (Basic)	0.05	1.90	2.40	5.75	6.55	4.65	4.00	2.70	2.45	3.30	3.25	3.55	3.90	3.75	3.55	3.60	3.10	2.70
EPS (Diluted)	0.05	1.90	2.40	5.75	6.55	4.65	4.00	2.70	2.45	3.30	3.25	3.55	3.90	3.75	3.55	3.60	3.10	2.70
EBITDA	12.68M	45.86M	26.83M	22.12M	37.52M	42.19M	57.38M	69.96M	72.86M	79.28M	75.46M	72.73M	72.75M	66.57M	63.16M	60.31M	56.18M	49.58M
EBIT	-94.28M	340.05M	411.57M	699.63M	752.75M	497.55M	429.87M	207.27M	190.46M	205.28M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Depreciation & Amortization	25.82M	49.79M	46.6M	40.84M	35.7M	34.56M	32.37M	30.52M	28.62M	23.02M	20.52M	20.68M	19.27M	17.64M	14.93M	13.4M	12.66M	12.23M